Corline Biomedical AB Cash Flow Quality Index
Corline Biomedical AB cash flow quality index. Corline Biomedical AB (CLBIO) has a Cash Flow Quality Index of -7.82x as of September 2023. Operating cash flow of Skr-1.60 Million is below net income of Skr204.00K, suggesting accrual-heavy earnings not yet converted to cash. Explore Corline Biomedical AB (CLBIO) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Corline Biomedical AB (2022–2022)
Cash flow quality index of Corline Biomedical AB from 2022 to 2022. Historical Cash Flow Quality Index for Corline Biomedical AB across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. See debt-free asset ratio of Corline Biomedical AB to measure how much of total assets are equity-financed.
Corline Biomedical AB Cash Flow Quality Index by Year (2022–2022)
Corline Biomedical AB cash flow quality index by year from 2022 to 2022. Year-by-year earnings quality comparison for Corline Biomedical AB. For the full cash flow conversion analysis, see Corline Biomedical AB (CLBIO) cash conversion ratio.
| Year | Quality Index | Operating CF (SEK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -2.77x | Skr-6.45 Million | Skr2.33 Million | — |